251 related articles for article (PubMed ID: 21849464)
1. A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.
Lu L; Palaniyandi S; Zeng R; Bai Y; Liu X; Wang Y; Pauza CD; Roopenian DC; Zhu X
J Virol; 2011 Oct; 85(20):10542-53. PubMed ID: 21849464
[TBL] [Abstract][Full Text] [Related]
2. CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.
Jiang JQ; Patrick A; Moss RB; Rosenthal KL
J Virol; 2005 Jan; 79(1):393-400. PubMed ID: 15596832
[TBL] [Abstract][Full Text] [Related]
3. Mucosal Priming with a Recombinant Influenza A Virus-Vectored Vaccine Elicits T-Cell and Antibody Responses to HIV-1 in Mice.
Wang J; Shu T; Deng W; Zheng Y; Liao M; Ye X; Han L; He P; Zheng X; Li T; Feng Y; Hu F; Li P; Sun C; Chen L; Li F; Feng L
J Virol; 2021 May; 95(12):. PubMed ID: 33789991
[TBL] [Abstract][Full Text] [Related]
4. Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.
Gu R; Stagnar C; Zaichenko L; Ramsingh AI
Vaccine; 2012 May; 30(24):3666-74. PubMed ID: 22464964
[TBL] [Abstract][Full Text] [Related]
5. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074
[TBL] [Abstract][Full Text] [Related]
6. FcRn-Targeted Mucosal Vaccination against Influenza Virus Infection.
Ochsner SP; Li W; Rajendrakumar AM; Palaniyandi S; Acharya G; Liu X; Wang G; Krammer F; Shi M; Tuo W; Pauza CD; Zhu X
J Immunol; 2021 Sep; 207(5):1310-1321. PubMed ID: 34380652
[TBL] [Abstract][Full Text] [Related]
7. Mucosal immunization with inactivated human immunodeficiency virus plus CpG oligodeoxynucleotides induces genital immune responses and protection against intravaginal challenge.
Dumais N; Patrick A; Moss RB; Davis HL; Rosenthal KL
J Infect Dis; 2002 Oct; 186(8):1098-105. PubMed ID: 12355360
[TBL] [Abstract][Full Text] [Related]
8. Induction of HIV immunity in the genital tract after intranasal delivery of a MVA vector: enhanced immunogenicity after DNA prime-modified vaccinia virus Ankara boost immunization schedule.
Gherardi MM; Pérez-Jiménez E; Nájera JL; Esteban M
J Immunol; 2004 May; 172(10):6209-20. PubMed ID: 15128809
[TBL] [Abstract][Full Text] [Related]
9. Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.
Singh S; Yang G; Byrareddy SN; Barry MA; Sastry KJ
Vaccine; 2014 Dec; 32(51):6934-6940. PubMed ID: 25444819
[TBL] [Abstract][Full Text] [Related]
10. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
[TBL] [Abstract][Full Text] [Related]
11. An HIV Envelope gp120-Fc Fusion Protein Elicits Effector Antibody Responses in Rhesus Macaques.
Shubin Z; Li W; Poonia B; Ferrari G; LaBranche C; Montefiori D; Zhu X; Pauza CD
Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404572
[TBL] [Abstract][Full Text] [Related]
12. Intensified and protective CD4+ T cell immunity in mice with anti-dendritic cell HIV gag fusion antibody vaccine.
Trumpfheller C; Finke JS; López CB; Moran TM; Moltedo B; Soares H; Huang Y; Schlesinger SJ; Park CG; Nussenzweig MC; Granelli-Piperno A; Steinman RM
J Exp Med; 2006 Mar; 203(3):607-17. PubMed ID: 16505141
[TBL] [Abstract][Full Text] [Related]
13. A dendritic cell targeted vaccine induces long-term HIV-specific immunity within the gastrointestinal tract.
Ruane D; Do Y; Brane L; Garg A; Bozzacco L; Kraus T; Caskey M; Salazar A; Trumpheller C; Mehandru S
Mucosal Immunol; 2016 Sep; 9(5):1340-52. PubMed ID: 26732678
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
15. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice.
Yoshizawa I; Mizuochi T; Ogata A; Murakami M; Yagita H; Takahashi Y; Mizuochi T; Takemori T; Tsunetsugu-Yokota Y
AIDS Res Hum Retroviruses; 2003 Jun; 19(6):469-79. PubMed ID: 12882656
[TBL] [Abstract][Full Text] [Related]
16. Intranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.
Yu F; Li Y; Guo Y; Wang L; Yang J; Zhao G; Zhou Y; Du L; Jiang S
Hum Vaccin Immunother; 2015; 11(12):2831-8. PubMed ID: 26260706
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell targeted HIV-1 gag protein vaccine provides help to a recombinant Newcastle disease virus vectored vaccine including mobilization of protective CD8
Ngu LN; Nji NN; Ambada G; Ngoh AA; Njambe Priso GD; Tchadji JC; Lissom A; Magagoum SH; Sake CN; Tchouangueu TF; Chukwuma GO; Okoli AS; Sagnia B; Chukwuanukwu R; Tebit DM; Esimone CO; Waffo AB; Park CG; Überla K; Nchinda GW
Immun Inflamm Dis; 2018 Mar; 6(1):163-175. PubMed ID: 29205929
[TBL] [Abstract][Full Text] [Related]
18. Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates.
Flynn BJ; Kastenmüller K; Wille-Reece U; Tomaras GD; Alam M; Lindsay RW; Salazar AM; Perdiguero B; Gomez CE; Wagner R; Esteban M; Park CG; Trumpfheller C; Keler T; Pantaleo G; Steinman RM; Seder R
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):7131-6. PubMed ID: 21467219
[TBL] [Abstract][Full Text] [Related]
19. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN
Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310
[TBL] [Abstract][Full Text] [Related]
20. Efficient mucosal vaccination mediated by the neonatal Fc receptor.
Ye L; Zeng R; Bai Y; Roopenian DC; Zhu X
Nat Biotechnol; 2011 Feb; 29(2):158-63. PubMed ID: 21240266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
